JPS5446885A - Stabilization of urokinase - Google Patents

Stabilization of urokinase

Info

Publication number
JPS5446885A
JPS5446885A JP11363677A JP11363677A JPS5446885A JP S5446885 A JPS5446885 A JP S5446885A JP 11363677 A JP11363677 A JP 11363677A JP 11363677 A JP11363677 A JP 11363677A JP S5446885 A JPS5446885 A JP S5446885A
Authority
JP
Japan
Prior art keywords
urokinase
guanine
deactivation
purification
during
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11363677A
Other languages
Japanese (ja)
Inventor
Nobuhiko Miwa
Hiroichi Takayanagi
Akira Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP11363677A priority Critical patent/JPS5446885A/en
Publication of JPS5446885A publication Critical patent/JPS5446885A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To prevent the deactivation and denaturation of urokinase, and to enable the reactivation of deactivated urokinase, by adding a guanine (derivative) to a urokinase-containing composition.
CONSTITUTION: The deactivation of urokinase during the purification of a crude urokinase solution obtained from human urine, or during the storage of purified urokinase powder, is prevented by adding 5×10-5W8×104 moles of a guanine dervative such as guanine and 1-methylguanine per 1 mole of protein in the urokinase. Purification of the urokinase solution is pref. carried out at a pH of 5W10, an ionic strength of 0.02W0.8 and a temperature of 0W15°C using a buffer solution containing acetic aicd, phosphoric aicd, etc. To improve the storage stability, the above stabilizer is added to the composition prior to freezing, drying etc.
COPYRIGHT: (C)1979,JPO&Japio
JP11363677A 1977-09-20 1977-09-20 Stabilization of urokinase Pending JPS5446885A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11363677A JPS5446885A (en) 1977-09-20 1977-09-20 Stabilization of urokinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11363677A JPS5446885A (en) 1977-09-20 1977-09-20 Stabilization of urokinase

Publications (1)

Publication Number Publication Date
JPS5446885A true JPS5446885A (en) 1979-04-13

Family

ID=14617248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11363677A Pending JPS5446885A (en) 1977-09-20 1977-09-20 Stabilization of urokinase

Country Status (1)

Country Link
JP (1) JPS5446885A (en)

Similar Documents

Publication Publication Date Title
DK8885A (en) N-HETEROCYCLYL-4-PIPERIDINAMINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
CA2113995A1 (en) Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
MX9202104A (en) ANTI-TRANSPIRANT COMPOSITIONS OF ACID-STABLE GEL BAR AND PROCEDURE FOR MAKING THEM
EA200001223A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
DK162883A (en) N-GLUCOSYLED CARBOXYLIC ACID AMIDE DERIVATIVES, PROCEDURES FOR PREPARING THEM AND THEIR USE FOR EFFECTING THE ORGANISM'S OWN DEFENSE MECHANISM
SE8102194L (en) THERAPEUTIC ACTIVE ORGANIC ASSOCIATION AND PHARMACEUTICAL PREPARATION INCLUDING THIS
FI854926A (en) FREEZING FOR PHARMACOLOGICAL ACTIVE PYRROLOBENSIMIDAZOLER.
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
EP0068563A3 (en) Heterocyclic acetic acid compounds and compositions for treating bone diseases
JPS5446885A (en) Stabilization of urokinase
DE3665320D1 (en) Stabilization of peroxidase activity in solution
NO157765C (en) PROCEDURE FOR THE PREPARATION OF AN ANTIMICROBIAL PREPARATION.
EP0365139A3 (en) Bile acids for the treatment of viral infections
MD1762B2 (en) Pyrazolyloxypyridine derivatives, process for obtaining thereof, herbicidal composition, process for weed plants control
DE3362725D1 (en) Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them
MY101266A (en) Pharmaceutical formulations
EP0008950A3 (en) Pyrimido(1,6-a)indole derivatives and intermediates therefor, processes for their preparation, pharmaceutical compositions containing the derivatives and their use
AU7971182A (en) Anthranilic acid derivatives
ES483076A1 (en) Process for the purification of tryptophane and derivatives of tryptophane
JPS5344572A (en) 5-alkoxy-picolic acid, its preparation and hypotensives containing the same
JPS5623891A (en) Stabilization of urokinaze by heating
JPS57155989A (en) Rpmi 1640 medium of high-pressure sterilization type
JPS5553299A (en) N2-substituted-phenyl-2,6-diaminonebularine
JPS5520711A (en) New 1,3,4-thiadiazol-5-ylthiol esters and their preparation
DK0710482T3 (en) Therapeutic agent for myocardial ischemic or reperfusion injuries